Genovare Pre-Filled Pen Premixed Aqueous
SpecsBuy PT-141 50mg AQ Pen in Dubai
Melanocortin agonist tested in phase 3 trials
AED 700 / pen
- Catalogue strength
- 50 mg
- Format
- Aqueous pre-filled pen
- Pack size
- 3mL
- Purity
- 99%+
Choose your bundle
Add AED 300 more for free UAE delivery
- OrderBefore 4 PM for Dubai
- PackedCold-chain, 2–8°C
- DeliveredSame day in Dubai, next day elsewhere in the UAE
Order before 4 PM for same-day Dubai delivery.
UAE delivery: AED 50 below AED 1,000; free from AED 1,000
Pay byCard payment linkUSDT
99%+ purityIn-house tested
- Sold by
- Remy Research
- Brand
- Genovare
- Manufacturer
- Genovare
- Tested by
- 99%+ line standard
- 99%+ purityLine standard
- Same-day DubaiOrder before 4 PM for same-day delivery
- FormatAqueous pre-filled pen
- Cold-chain packed2–8°C
Genovare PT 141 50mg Pen: What the Research Shows
- Average desire gain 0.5–0.6 vs 0.2 placebo
- Average distress drop 0.7 vs 0.4 placebo
- Desire gains held across 52 weeks
Published study results for the compound, not results from this product. For research use only.
Genovare PT 141 50mg Pen is a 3mL aqueous pre-filled research pen containing 50 mg of PT-141 (bremelanotide), a synthetic melanocortin receptor agonist supplied for in-vitro laboratory research rather than approved medical use.
For researchers and scientists who need clear product specifications before ordering, this page brings together the details that affect handling and study planning: 99%+ purity, pen format, pack size, cold-chain delivery, storage conditions, chemical and product data, comparisons with related options, research context, regulatory status, and UAE ordering information.
Genovare PT 141 50mg pen is a Genovare-labelled 3mL pre-filled aqueous research pen containing a catalogue strength of 50 mg PT-141 (bremelanotide), a synthetic melanocortin receptor agonist; it is presented here for in-vitro laboratory research only and not as an approved medicine. This page is written for researchers and scientists who need a clear snapshot of the product’s stated format, and how it differs from authorised bremelanotide products.
PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide studied as an agonist at several melanocortin-receptor subtypes. The Genovare 3mL pen is labelled 50mg, but no sequence, salt or formulation-equivalence evidence is supplied. You’ll also find the key handling and buying details researchers usually check first: stated specifications, storage guidance, what is included, delivery context in the UAE, and the compound’s research and regulatory status, including its distinction from approved medicines such as Vyleesi.
- Pack Size
- 3mL
- Product details
- Genovare Catalogue
- Pre-Filled Pen
- Premixed Aqueous
- Storage Guidance
- Follow Package Label
- 1 pre-filled Genovare research pen
- 3 pen needles
- Genovare retail packaging
Other formats of PT-141
Ships from Dubai
PT-141 50mg AQ Pen: what it is
PT-141, or bremelanotide, is a synthetic cyclic seven-amino-acid peptide that activates melanocortin receptors. It is closely related to Melanotan II: the two share the same ring, and bremelanotide carries a free acid at its C-terminus where Melanotan II carries an amide.
Genovare supplies this pen ready-made: the peptide is already dissolved in an aqueous solution, and the catalogue lists it at 50 mg in a 3mL fill. Bremelanotide is the active substance of Vyleesi, a prescription medicine in the US, but this pen is a separate Genovare product, and the Vyleesi label's quality and safety data do not apply to it.
No regulator has approved this pen as a medicine. Remy Research sells it for in-vitro laboratory research only, not for human or veterinary use.
Batch status, storage and delivery
Batch status
Its testing line reads "99%+ line standard". Every report published so far is listed in the lab results library.
Storage and handling
Remy Research ships this pen cold-chain packed at 2–8°C, with live order tracking. After delivery, store it as the Genovare pack label directs: the label, not a general rule, sets the conditions for this product.
The peptide is already in solution, and supplier guides say a peptide solution tolerates heat far less well than dry powder; they also advise keeping peptides away from bright light. The stretch between the door and storage is the part the cold chain does not cover. A parked car in a UAE summer runs well above 40°C, the temperature of the accelerated condition (40°C at 75% relative humidity) in the ICH Q1A(R2) pharmaceutical stability-testing guideline, so a car is not a holding place even for a short errand.
If the pen spends time outside its labelled range, note how long and how warm it got. A clear solution is not proof of quality: only a retest, for example by HPLC, shows whether the peptide has changed. The peptide storage and shelf-life guide sets out the sourced figures.
Delivery in the UAE
Dubai orders placed before 4 PM are delivered the same day. In the other emirates, orders placed before 12 PM (noon) arrive the next day, otherwise within two days, and Saturday orders outside Dubai arrive on Monday. Delivery costs AED 50 below AED 1,000 and is free from AED 1,000; the minimum order is AED 400. Full terms are on the delivery page.
Chemistry · Reference dataPT-141 chemistry & specifications
Identity
Cyclic melanocortin-receptor agonist peptide
Bremelanotide (PT-141)
Also known asBremelanotide, PT141, PT 141
- CAS
- 189691-06-3
Molecule
- Formula
- C50
H68 N14 O10 - Molecular weight
- 1,025.2 g/mol Registry value for the peptide without counter-ions; not measured for this batch.
- Sequence
- Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys
- Note
- Nle is norleucine.
This product
- Manufacturer
- Genovare
- Catalogue strength
- 50 mg
- Fill volume
- 3mL
- Format
- Aqueous pre-filled pen
- Pack size
- 1 pen with 3 needles
Batch documentation
99%+ line standard
Every report we have published is listed in the lab results library.
Reference data for laboratory checks. Registry values describe the compound, not measurements of this batch. For research use only.
What the literature says
Bremelanotide holds an FDA approval: Vyleesi was approved on 21 June 2019 for premenopausal women with acquired, generalized hypoactive sexual desire disorder that is not due to another medical or psychiatric condition, a relationship problem or a medicine. It is thought to act on the central nervous system, specifically the hypothalamus, and to alter neurotransmitter signaling in the brain, including dopamine pathways, to influence sexual motivation and response rather than directly increasing blood flow, although the Vyleesi label states that its mechanism is unknown. Common side effects listed on the Vyleesi label include nausea, flushing, and headaches, and temporary blood pressure increases with heart rate decreases may occur. That approval covers Vyleesi in that population, not this pen. The PT-141 research review covers the trial record and the melanocortin biology. Off-label use for erectile dysfunction in men has been investigated, but effectiveness is less established and it is not approved for enhancing overall sexual performance.
Frequently Asked Questions
What are the chemical identifiers of PT-141?
Bremelanotide (PT-141) has CAS number 189691-06-3, molecular formula C50H68N14O10, molecular weight 1,025.2 g/mol, PubChem CID 9941379. These are registry values for the compound, not measurements of a batch.
Which PT-141 formats have a published batch report?
Among the related formats Remy Research lists, published Janoshik reports exist for the ProPeptide PT-141 20mg Pen (batch PT20P-001). Every published report is listed in the lab results library.
How does this pen differ from the other formats?
This Genovare pen holds 50 mg as an aqueous solution in a pre-filled pen. Remy Research also lists 2 related formats from ProPeptide; the comparison table on this page sets out their compounds, formats and batch documentation.
How is this pen shipped and stored?
Remy Research ships it cold-chain packed at 2–8°C, with live order tracking. After delivery, the storage conditions printed on the Genovare pack apply. The peptide is already in solution, which tolerates heat far less well than dry powder, so keep the pen out of bright light and out of parked cars.
Is this pen the same as Vyleesi?
No. Bremelanotide (PT-141) is the active substance of Vyleesi, which FDA approved in 2019 for acquired, generalized hypoactive sexual desire disorder in premenopausal women. This pen is a separate Genovare product, and no regulator has approved it as a medicine. Remy Research sells it for in-vitro laboratory research only, not for human or veterinary use.
How fast is delivery in the UAE?
Dubai orders placed before 4 PM are delivered the same day. In the other emirates, orders placed before 12 PM (noon) arrive the next day, otherwise within two days, and Saturday orders outside Dubai arrive on Monday. Delivery costs AED 50 below AED 1,000 and is free from AED 1,000; the minimum order is AED 400.
Does Remy Research sell PT-141 nasal spray?
Remy Research lists PT-141 in three formats: this Genovare 50mg aqueous pre-filled pen (3mL, AED 700), a ProPeptide 20mg pen and a ProPeptide 10mg vial. A nasal spray is not listed. The ProPeptide 20mg pen has a published Janoshik report, batch PT20P-001. All are sold for in-vitro laboratory research only.
Can I buy the Genovare PT-141 50mg AQ pen online in the UAE?
Remy Research, a Dubai-based supplier, lists the Genovare PT-141 50mg AQ pen at AED 700 for in-vitro laboratory research only. Ordering takes place on the website. Delivery reaches all seven emirates. A minimum order of AED 400 applies, and no walk-in store or pickup point exists.



